Small Molecule Outsourcing STREAM

  1. A Data-Driven Approach To Container Closure Integrity

    Gain confidence in your container closure system selection by utilizing a stepwise and data-driven approach to predicting and verifying container closure integrity.

  2. The Paradigm Shift To Continuous Flow Processes: A Holistic View

    A clear increase in continuous flow processes has emerged over the past decade, thanks to the commercialization of preparative flow reactor units.

  3. Small Molecule APIs: From Pre-RSM To Final API 8/31/2023

    As a leader in small molecule manufacturing, Ajinomoto Bio-Pharma Services has over 40 years of experience providing high quality APIs and intermediates for pharmaceutical companies throughout the world.

  4. The Key To HPAPI Manufacturing Success 3/1/2024

    Watch to explore a training center dedicated to the development and manufacturing of HPAPIs that is setting a new industry standard for safety and expertise.

  5. Discovering A Unique Multimillion Euro Nanotechnology Facility 10/25/2024

    Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.

  6. Improve The Bioavailability Of Poorly Soluble Drugs 3/19/2024

    KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.

  7. Cambrex Scientist Spotlight: TJ Harper 1/29/2025

    With a Master’s in chemistry from the University of North Carolina, Harper has designed and built several laboratory spaces to meet cGMP requirements, ensuring quality and compliance in every project.

  8. Sustainability By Design In API Manufacturing 7/29/2025

    Explore the urgent need for sustainability in small molecule API manufacturing, as well as reveal regulatory drivers, green chemistry innovations, and practical strategies to reduce emissions.

  9. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

    Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

  10. Strategic CMC Planning Through A Phase-Appropriate Quality Approach 5/28/2024

    A phase-appropriate quality approach ensures quality activities align with the unique risks and challenges of each development stage. Watch to learn how to apply such an approach to chemistry, manufacturing, and controls planning.